The UK Medicines and Healthcare products Regulatory Agency (MHRA) recently approved Amgen’s bone cancer drug Xgeva (denosumab), the first drug … Read…
“The Association of the British Pharmaceutical Industry (ABPI) trade organisation has broadly welcomed the addition of a new route…
Over half (54%) of the surveyed healthcare industry professionals indicated that their sentiment towards Brexit had become more negative. Read More
Swiss firm’s withdrawal from Leqvio trial with NHS dents government plans to attract post-Brexit research and investment The Swiss pharmaceutical…
The burden of having to produce separate product packs for Great Britain and Northern Ireland is among a number of…
The Nuffield Trust said a recent example of a product licensed in Great Britain but not Northern Ireland is a…
A complete shortage of a blood thinner drug dose is recorded in Cyprus due to Brexit, with health officials urging…
https://www.chichester.co.uk/business/sussex-business-cuts-dozens-of-jobs-after-losing-90-of-trade-to-brexit-3165363